CRISPR Therapeutics AG ($CRSP) Stock Forecast: Up 16.6% Today

What is CRISPR Therapeutics AG?

CRISPR Therapeutics (NASDAQ: CRSP) is a biotech company focused on developing transformative gene-based medicines using its proprietary CRISPR/Cas9 technology. The company aims to treat genetic disorders and other diseases.

Why is CRISPR Therapeutics AG going up?

CRSP stock is up 16.6% on Feb 14, 2025 14:43

• The bullish movement in CRSP stock today is linked to positive Q4 earnings and revenue surpassing estimates, indicating strong financial performance and market confidence in the company's innovative gene therapy solutions.
• An analyst upgrade from Telsey Advisory Group may have also contributed to the positive sentiment, showing increased optimism and potential future growth prospects for CRISPR Therapeutics.
• The successful commercial launch of Casgevy, the first CRISPR-based gene therapy, further strengthens investor confidence in CRSP's technological advancements and market potential, leading to an increase in the stock price.

CRSP Price Chart

CRSP Technical Analysis

CRSP News

This Roku Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday - CRISPR Therapeutics ( NASDAQ:CRSP ) , Airbnb ( NASDAQ:ABNB )

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Telsey Advisory Group analyst Joseph Feldman upgraded Floor & Decor Holdings, Inc.

https://www.benzinga.com/25/02/43728633/this-roku-analyst-turns-bullish-here-are-top-5-upgrades-for-friday

CRISPR Therapeutics Q4 Earnings and Revenues Surpass Estimates

CRSP reports encouraging fourth-quarter results. The commercial launch of the first CRISPR-based gene therapy, Casgevy, is progressing well.

https://www.zacks.com/stock/news/2414454/crispr-therapeutics-q4-earnings-and-revenues-surpass-estimates

Trending Today

Dogecoin ($DOGE) Crypto Forecast: Down 5.2% Today

Movement ($MOVE) Crypto Forecast: Down 6.8% Today

Mantle ($MNT) Crypto Forecast: Down 11.8% Today

Litecoin ($LTC) Crypto Forecast: Down 5.4% Today

Hedera Hashgraph ($HBAR) Crypto Forecast: Down 5.0% Today

dogwifhat ($WIF) Crypto Forecast: Down 5.5% Today

Arbitrum ($ARB) Crypto Forecast: Down 5.6% Today

Bonk ($BONK) Crypto Forecast: Down 5.8% Today

Wormhole ($W) Crypto Forecast: Down 7.1% Today

Memecoin ($MEME) Crypto Forecast: Down 5.1% Today

CRISPR Therapeutics AG Price History

03.11.2024 - CRSP Stock was down 5.1%

• Analysts project a potential upside of 58.3% for CRSP.
• Earnings estimate revisions show a positive trend, hinting at potential future stock growth.
• Despite optimistic analyst outlook, CRSP's stock witnessed a bearish movement today, signaling a discrepancy between predictions and market performance.

22.00.2025 - CRSP Stock was up 7.1%

• Recent significant trades involving CRISPR Therapeutics AG by a well-known investment firm could have sparked investor optimism and confidence in the company's future prospects.
• The recent uptrend in CRSP's stock price may be a result of heightened attention from both individual and institutional investors following the mentioned investment firm's positions in the company.
• Continued interest from the investment firm in CRSP suggests a strong belief in the potential of CRISPR gene-editing technology, contributing to positive sentiment and driving the stock price up.
• The market's response indicates that investors perceive CRSP as a significant player in the biotech industry with promising growth opportunities, resulting in increased buying interest and a rise in the stock price.

06.00.2025 - CRSP Stock was up 4.4%

• CRSP stock demonstrated a robust bullish trend, rising by +1.84% despite overall market conditions.
• The upsurge in CRSP stock could be linked to favorable developments in the company's CRISPR technology.
• Investors may be hopeful about CRSP's future possibilities, prompting heightened buying interest.
• CRSP's steady performance amidst market fluctuations may suggest high investor trust in the company's innovative gene-based therapies approach.

28.09.2024 - CRSP Stock was up 1.6%

• CRISPR Therapeutics AG (CRSP) displayed a bullish movement, diverging from the general market direction.
• Investors were likely encouraged by the anticipated Q3 earnings, especially the sales performance of its gene therapy Casgevy.
• Despite recent fluctuations, CRSP's favorable trajectory could be linked to growing investor confidence in its pioneering gene-based treatments.
• The market's positive reception of CRSP's potential for expansion may have eclipsed broader market patterns, contributing to its upward momentum.

08.00.2025 - CRSP Stock was down 5.3%

• Key factors contributing to the bearish movement in CRSP stock include:
• Closing at $41.92, reflecting a -1.2% decrease from the prior trading session.
• Negative market sentiment influencing the stock more than the overall market.
• Potential profit-taking by investors following a recent price surge.
• Uncertainty surrounding regulatory approvals for CRISPR-based therapies impacting investor confidence.

05.01.2025 - CRSP Stock was up 5.1%

• CRISPR Therapeutics AG (CRSP) exhibited strong bullish movement today, surpassing the overall stock market performance.
• Investor confidence in CRISPR Therapeutics AG (CRSP) might have been bolstered by Cathie Wood's Ark Invest's positioning, influencing the positive stock movement.
• The company's emphasis on innovative gene-based therapies could have contributed to the optimistic investor sentiment.
• The bullish movement in CRSP stock today may be attributed to the favorable market sentiment, strategic investments by influential entities like Ark Invest, and the promising future of CRISPR technology.

23.09.2024 - CRSP Stock was down 5.1%

• The downward movement in CRISPR Therapeutics AG (CRSP) may be due to investors taking profits following a recent upturn.
• The potential decrease in CRISPR Therapeutics AG (CRSP) could have been influenced by a major investment firm reducing its stakes in other companies, causing a broader negative market sentiment.
• Despite optimistic forecasts by financial analysts for CRISPR Therapeutics AG (CRSP), current market conditions and profit-taking behaviors likely outweighed the positive outlook, leading to the bearish movement observed today.

11.10.2024 - CRSP Stock was up 6.2%

• Analysts are optimistic about CRISPR Therapeutics, with a mean price target suggesting a significant upside potential of 62.8% in the stock.
• Despite mixed third-quarter results, including a narrower loss than expected and sales missing estimates, the progress in the commercial launch of Casgevy, the first CRISPR-based gene therapy, is a positive indicator for the company's future growth prospects.
• The bullish movement in CRSP today could be attributed to the overall positive sentiment from analysts regarding the company's potential and the advancements in its groundbreaking gene-editing technology.

05.10.2024 - CRSP Stock was down 5.6%

• The strong bearish movement in CRSP today could be attributed to profit-taking by investors after the stock recently surpassed both the 20-day and 50-day moving averages.
• Some investors who closely follow technical analysis may have seen these moving average milestones as potential signals to sell, leading to a temporary downturn in the stock price.
• Despite the bearish movement, the long-term outlook for CRSP remains positive, given its innovative technologies and promising pipeline of gene-based therapies.

23.00.2025 - CRSP Stock was up 5.1%

• CRISPR Therapeutics (CRSP) experienced a strong bullish movement today, with shares surging by 6.5%.
• The increased trading volume and positive trend in earnings estimate revisions contributed to the stock's upward momentum.
• Significant trades involving CRSP by an influential investment firm could have also fueled investor optimism and buying interest in the stock.
• The market seems to be reacting positively to the company's recent developments and the overall bullish sentiment in the biotech sector.

14.01.2025 - CRSP Stock was up 16.6%

• The bullish movement in CRSP stock today is linked to positive Q4 earnings and revenue surpassing estimates, indicating strong financial performance and market confidence in the company's innovative gene therapy solutions.
• An analyst upgrade from Telsey Advisory Group may have also contributed to the positive sentiment, showing increased optimism and potential future growth prospects for CRISPR Therapeutics.
• The successful commercial launch of Casgevy, the first CRISPR-based gene therapy, further strengthens investor confidence in CRSP's technological advancements and market potential, leading to an increase in the stock price.

12.01.2025 - CRSP Stock was up 8.1%

• Strong Q4 earnings and revenues were reported by CRSP, surpassing estimates.
• The successful commercial launch of Casgevy, the first CRISPR-based gene therapy, contributed to the bullish movement.
• Investor confidence in CRSP's innovative gene therapy solutions likely drove the stock price higher.